Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
A-Mark Precious Metals	AMRK	28. mar 2025	26.45	-6.90
a.k.a Brands	AKA	28. mar 2025	14.29	-0.97
A.O Smith	AOS	28. mar 2025	65.61	-1.93
A10 Networks	ATEN	28. mar 2025	16.74	-3.07
A2Z Cust2Mate Solutions	AZ	28. mar 2025	7.31	-1.48
AA Mission Acquisition	AAM	28. mar 2025	10.28	+0.10
AAA - A Rated Corporate Bond Ishares	QLTA	28. mar 2025	47.44	+0.47
Aadi Bioscience	AADI	28. mar 2025	2.05	0.00
AAON	AAON	28. mar 2025	78.08	-2.69
AAR	AIR	28. mar 2025	57.14	-16.40
Aardvark Therapeutics	AARD	28. mar 2025	7.74	0.00
Abacus Global Management	ABL	28. mar 2025	7.62	+6.57
Abbott Laboratories	ABT	28. mar 2025	130.82	-0.40
AbbVie	ABBV	28. mar 2025	205.29	+1.27
AbCellera Biologics	ABCL	28. mar 2025	2.31	-2.12
Abeona Therapeutics	ABEO	28. mar 2025	4.97	-1.39
Abercrombie & Fitch	ANF	28. mar 2025	76.57	-1.24
Aberdeen Asia-Pacificome Fund	FAX	28. mar 2025	15.67	+0.19
Aberdeen Australia Equity Fund	IAF	28. mar 2025	4.06	-0.25
Aberdeen Emerging Markets Fund	AEF	28. mar 2025	5.00	-1.96
Aberdeen Global Fund	FCO	28. mar 2025	6.03	+0.33
Aberdeen Global Infrastructure	ASGI	28. mar 2025	18.49	+0.98
Aberdeen Income Credit Strategies Fund	ACP	28. mar 2025	5.91	-0.17
Aberdeen Income Credit Strategies Pref	ACP-A	28. mar 2025	21.43	-0.65
Aberdeen Japan Equity Fund	JEQ	28. mar 2025	6.59	-1.64
Abits Group	ABTS	28. mar 2025	3.28	+3.71
Abivax SA - American Depositary Shares	ABVX	28. mar 2025	6.43	-5.72
Able View Global	ABLV	28. mar 2025	0.95	+5.34
ABM Industries	ABM	28. mar 2025	47.32	-1.79
Above Food Ingredients	ABVE	28. mar 2025	0.58	-15.31

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.